Population-based case-control study of morale in Parkinson's disease

被引:19
作者
Benito-Leon, J. [2 ]
Louis, E. D. [1 ,3 ,4 ,5 ]
Bermejo-Pareja, F. [2 ]
机构
[1] Columbia Univ, GH Sergievsky Ctr, New York, NY 10027 USA
[2] Univ Hosp 12 Octubre, Dept Neurol, Madrid, Spain
[3] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA
[4] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA
[5] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA
关键词
epidemiology; morale; Parkinson's disease; quality of life; QUALITY-OF-LIFE; ESSENTIAL TREMOR; CENTRAL SPAIN; SCALE; DEPRESSION; PREVALENCE;
D O I
10.1111/j.1468-1331.2008.02428.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Parkinson's disease (PD) is associated with cognitive, psychiatric, and motor features. Each could contribute to a poor sense of well-being and low morale. A systematic study of morale in community-dwelling PD cases has not been performed. A total of 52 PD cases and 260 matched controls from three Spanish communities were assessed using the Philadelphia Geriatric Center Morale Scale (PGCMS) (range = 0[low morale]-17). The PGCMS includes three dimensions of psychological well-being: agitation, lonely dissatisfaction, and attitude toward own aging. The PGCMS score was lower in PD cases than controls (8.71 +/- 3.64 vs. 11.03 +/- 2.77, P < 0.001), as were the agitation subscore (3.36 +/- 1.91 vs. 4.07 +/- 1.59, P < 0.05), lonely dissatisfaction subscore (3.48 +/- 1.36 vs. 4.11 +/- 1.12, P < 0.01), and attitude toward own aging subscore (1.86 +/- 1.37 vs. 2.85 +/- 1.13, P < 0.001). In a linear regression analysis that adjusted for depressive symptoms and other covariates, PD cases had a lower PGCMS score than controls (P < 0.001). Morale was significantly lower in community-dwelling PD cases than matched controls. The detection and possible treatment of this problem may improve the psychological well-being of patients with this disease.
引用
收藏
页码:330 / 336
页数:7
相关论文
共 28 条
[1]
Parkinson's disease and parkinsonism in a longitudinal study - Two-fold higher incidence in men [J].
Baldereschi, M ;
Di Carlo, A ;
Rocca, WA ;
Vanni, P ;
Maggi, S ;
Perissinotto, E ;
Grigoletto, F ;
Amaducci, L ;
Inzitari, D .
NEUROLOGY, 2000, 55 (09) :1358-1363
[2]
Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain [J].
Benito-León, J ;
Bermejo-Pareja, F ;
Rodríguez, J ;
Molina, JA ;
Gabriel, R ;
Morales, JM .
MOVEMENT DISORDERS, 2003, 18 (03) :267-274
[3]
Problems and issues with door-to-door, two-phase surveys: An illustration from central Spain [J].
Bermejo, F ;
Gabriel, R ;
Vega, S ;
Morales, JM ;
Rocca, WA ;
Anderson, DW .
NEUROEPIDEMIOLOGY, 2001, 20 (04) :225-231
[4]
Dall J., 1992, Standardised assessment scales for elderly people
[5]
Quality of life and related concepts in Parkinson's disease: A systematic review [J].
Den Oudsten, Brenda L. ;
Van Heck, Gnus L. ;
De Vries, Jolanda .
MOVEMENT DISORDERS, 2007, 22 (11) :1528-1537
[6]
Prevalence of Parkinson's disease in the elderly: The Rotterdam study [J].
deRijk, MC ;
Breteler, MMB ;
Graveland, GA ;
Ott, A ;
Grobbee, DE ;
vanderMeche, FGA ;
Hofman, A .
NEUROLOGY, 1995, 45 (12) :2143-2146
[7]
Depressive symptoms and treatment after acute coronary syndrome [J].
Ellis, JJ ;
Eagle, KA ;
Kline-Rogers, EM ;
Erickson, SR .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 99 (03) :443-447
[8]
Fahn S., 1987, RECENT DEV PARKINSON, V2, P293, DOI DOI 10.2490/JJRMC.47.791
[9]
PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].
HOEHN, MM ;
YAHR, MD .
NEUROLOGY, 1967, 17 (05) :427-&
[10]
Outcomes associated with pharmacologic treatments in Parkinson's disease: a review of recent literature [J].
Iaconi, Ala I. ;
Zimmerman, Marliese A. ;
Kulkarni, Amit S. ;
Balkrishnan, Rajesh .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (02) :163-174